Polyomaviruses BK and JC are ubiquitous viruses with high seroprevalence rates in general population.Following primary infection,polyomaviruses BK and JC persist latently in different sites,particularly in the reno-ur...Polyomaviruses BK and JC are ubiquitous viruses with high seroprevalence rates in general population.Following primary infection,polyomaviruses BK and JC persist latently in different sites,particularly in the reno-urinary tract.Reactivation from latency may occur in normal subjects with asymptomatic viruria,while it can be associated to nephropathy(PVAN)in kidney transplantat recipients.PVAN may occur in 1%-10%of renal transplant patients with loss of the transplanted organ in 30%up to 80%of the cases.Etiology of PVAN is mainly attributable to BK virus,although approximately5%of the cases may be due to JC.Pathogenesis of PVAN is still unknown,although viral replication and the lack of immune control play a major role.Immunosuppression represents the condicio sine qua non for the development of PVAN and the modulation of anti-rejection treatment represents the first line of intervention,given the lack of specific antiviral agents.At moment,an appropriate immunemodulation can only be accomplished by early identification of viral reactivacation by evaluation of polyomavirus load on serum and/or urine specimens,particularly in the first year post-trasplantation.Viro-immunological monitoring of specific cellular immune response could be useful to identify patients unable to recover cellular immunity posttransplantation,that are at higher risk of viral reactivation with development of PVAN.Herein,the main features of polyomaviruses BK and JC,biological properties,clinical characteristics,etiopathogenesis,monitoring and diag-nosing of PVAN will be described and discussed,with an extended citation of related relevant literature data.展开更多
文摘Polyomaviruses BK and JC are ubiquitous viruses with high seroprevalence rates in general population.Following primary infection,polyomaviruses BK and JC persist latently in different sites,particularly in the reno-urinary tract.Reactivation from latency may occur in normal subjects with asymptomatic viruria,while it can be associated to nephropathy(PVAN)in kidney transplantat recipients.PVAN may occur in 1%-10%of renal transplant patients with loss of the transplanted organ in 30%up to 80%of the cases.Etiology of PVAN is mainly attributable to BK virus,although approximately5%of the cases may be due to JC.Pathogenesis of PVAN is still unknown,although viral replication and the lack of immune control play a major role.Immunosuppression represents the condicio sine qua non for the development of PVAN and the modulation of anti-rejection treatment represents the first line of intervention,given the lack of specific antiviral agents.At moment,an appropriate immunemodulation can only be accomplished by early identification of viral reactivacation by evaluation of polyomavirus load on serum and/or urine specimens,particularly in the first year post-trasplantation.Viro-immunological monitoring of specific cellular immune response could be useful to identify patients unable to recover cellular immunity posttransplantation,that are at higher risk of viral reactivation with development of PVAN.Herein,the main features of polyomaviruses BK and JC,biological properties,clinical characteristics,etiopathogenesis,monitoring and diag-nosing of PVAN will be described and discussed,with an extended citation of related relevant literature data.
